{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:37:00Z","timestamp":1786581420834,"version":"build-2736575974"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","award":["RM11916B890516B3"],"award-info":[{"award-number":["RM11916B890516B3"]}],"id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ejinme.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ejim.2025.03.034","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T12:37:32Z","timestamp":1743770252000},"page":"98-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Differential modulations of miRNAs in patients with systemic sclerosis-associated skeletal muscle loss"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8863-3459","authenticated-orcid":false,"given":"Federica","family":"Tambaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2015-765X","authenticated-orcid":false,"given":"Antonietta","family":"Gigante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3634-014X","authenticated-orcid":false,"given":"Carmen","family":"Gallicchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1077-4846","authenticated-orcid":false,"given":"Chiara","family":"Pellicano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesarina","family":"Ramaccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Belli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ludovica","family":"Gasperini-Zacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7417-8093","authenticated-orcid":false,"given":"Edoardo","family":"Rosato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Muscaritoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2025.03.034_bib0001","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2025.03.034_bib0002","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2025.03.034_bib0003","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/art.40560","article-title":"Treatment algorithms for systemic sclerosis according to experts","volume":"70","author":"Fern\u00e1ndez-Codina","year":"2018","journal-title":"Arthritis Rheumatol (Hoboken, N.J.)"},{"key":"10.1016\/j.ejim.2025.03.034_bib0004","first-page":"202","article-title":"Scleroderma (Systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2025.03.034_bib0005","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s10067-022-06059-5","article-title":"Symptoms related to gastrointestinal tract involvement and low muscularity in systemic sclerosis","volume":"41","author":"Rosato","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ejim.2025.03.034_bib0006","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-078034","article-title":"Open Access sarcopenia in systemic sclerosis: prevalence and impact-a systematic review and meta-analysis","volume":"14","author":"Tu","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejim.2025.03.034_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21165678","article-title":"Sarcopenia in autoimmune and rheumatic diseases: a comprehensive review","volume":"21","author":"An","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejim.2025.03.034_bib0008","doi-asserted-by":"crossref","unstructured":"Spanjer, M.J.; Bultink, I.E.M.; De Van Der Schueren, M.A.E.; Voskuyl, A.E. Concise report prevalence of malnutrition and validation of bioelectrical impedance analysis for the assessment of body composition in patients with systemic sclerosis., doi:10.1093\/rheumatology\/kex014.","DOI":"10.1093\/rheumatology\/kex014"},{"key":"10.1016\/j.ejim.2025.03.034_bib0009","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3899\/jrheum.170437","article-title":"Clinical correlates, outcomes, and predictors of inflammatory ocular disease associated with rheumatoid arthritis in the biologic era","volume":"45","author":"Caimmi","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2025.03.034_bib0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.nut.2018.03.046","article-title":"Prevalence of sarcopenia in systemic sclerosis: assessing body composition and functional disability in patients with systemic sclerosis","volume":"55\u201356","author":"Siegert","year":"2018","journal-title":"Nutrition"},{"key":"10.1016\/j.ejim.2025.03.034_bib0011","first-page":"23","article-title":"The involvement of smooth muscle, striated muscle, and the myocardium in scleroderma: a review","author":"Bratoiu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejim.2025.03.034_bib0012","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1007\/s10067-020-05141-0","article-title":"Reduction of fat free mass index and phase angle is a risk factor for development digital ulcers in systemic sclerosis patients","volume":"39","author":"Rosato","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ejim.2025.03.034_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102396","article-title":"Role of MicroRNA in the pathogenesis of systemic sclerosis tissue fibrosis and vasculopathy","volume":"18","author":"Henry","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ejim.2025.03.034_bib0014","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41576-018-0074-2","article-title":"Clinical epigenetics: seizing opportunities for translation","volume":"20","author":"Berdasco","year":"2019","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.ejim.2025.03.034_bib0015","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41584-021-00683-2","article-title":"Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential","volume":"17","author":"Tsou","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ejim.2025.03.034_bib0016","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.molmed.2019.02.001","article-title":"The role of epigenetic modifications in systemic sclerosis: a druggable target","volume":"25","author":"Henderson","year":"2019","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ejim.2025.03.034_bib0017","first-page":"21","article-title":"Epigenetics as a versatile regulator of fibrosis","author":"Liu","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.ejim.2025.03.034_bib0018","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/1756-185X.13924","article-title":"Meta-analysis of differentially expressed micrornas in systemic sclerosis","volume":"23","author":"Zhang","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.ejim.2025.03.034_bib0019","first-page":"13","article-title":"The roles of noncoding RNAs in systemic sclerosis","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejim.2025.03.034_bib0020","first-page":"1","article-title":"Novel players in the diagnosis and treatment of cancer cachexia (Review)","volume":"24","author":"Li","year":"2022","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.ejim.2025.03.034_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.607196","article-title":"MicroRNAs in skeletal muscle and hints on their potential role in muscle wasting during cancer cachexia","volume":"10","author":"Marceca","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejim.2025.03.034_bib0022","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1002\/jcsm.13343","article-title":"Small non-coding RNA profiling in patients with gastrointestinal cancer","volume":"14","author":"Molfino","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ejim.2025.03.034_bib0023","first-page":"11","article-title":"Circulating adipose-tissue MiRNAs in gastrointestinal cancer patients and their association with the level and type of adiposity at body composition analysis","author":"Tambaro","year":"2024","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.ejim.2025.03.034_bib0024","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 Classification criteria for systemic sclerosis: an american college of Rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"Van Den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2025.03.034_bib0025","first-page":"1281","article-title":"Inter and intraobserver variability of total skin thickness score (Modified Rodnan TSS) in systemic sclerosis","volume":"22","author":"Clements","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2025.03.034_bib0026","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/annrheumdis-2016-209768","article-title":"The European scleroderma trials and research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index","volume":"76","author":"Valentini","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2025.03.034_bib0027","first-page":"2159","article-title":"A disease severity scale for systemic sclerosis: development and testing","volume":"26","author":"Medsger","year":"1999","journal-title":"J Rheumatol"},{"issue":"Suppl 4","key":"10.1016\/j.ejim.2025.03.034_bib0028","article-title":"Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement?","volume":"45","author":"Cutolo","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejim.2025.03.034_bib0029","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.clnu.2015.03.001","article-title":"Diagnostic criteria for malnutrition - An ESPEN consensus statement","volume":"34","author":"Cederholm","year":"2015","journal-title":"Clin Nutr"},{"key":"10.1016\/j.ejim.2025.03.034_bib0030","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative CT method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ejim.2025.03.034_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102494","article-title":"Gender-related differences in systemic sclerosis","volume":"19","author":"Hughes","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ejim.2025.03.034_bib0032","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/art.1780220205","article-title":"Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma","volume":"22","author":"Rodnan","year":"1979","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2025.03.034_bib0033","first-page":"24","article-title":"Endothelial dysfunction in systemic sclerosis","author":"Patnaik","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejim.2025.03.034_bib0034","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.clnu.2018.10.018","article-title":"Performance of CT-based low skeletal muscle index, low mean muscle attenuation, and bioelectric impedance derived low phase angle in the detection of an increased risk of nutrition related mortality","volume":"38","author":"Viertel","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.ejim.2025.03.034_bib0035","first-page":"107","article-title":"Phase angle, nutritional status, and mortality in systemic sclerosis: an exploratory pilot study","author":"Rosato","year":"2023","journal-title":"Nutrition"},{"key":"10.1016\/j.ejim.2025.03.034_bib0036","first-page":"1","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.ejim.2025.03.034_bib0037","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5114\/reum.2019.87619","article-title":"Systemic sclerosis - Multidisciplinary disease: clinical features and treatment","volume":"57","author":"Sobolewski","year":"2019","journal-title":"Reumatologia"},{"key":"10.1016\/j.ejim.2025.03.034_bib0038","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s10067-017-3932-y","article-title":"Malnutrition and sarcopenia in a large cohort of patients with systemic sclerosis","volume":"37","author":"Caimmi","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ejim.2025.03.034_bib0039","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40618-020-01364-9","article-title":"Body composition and microvascular damage in systemic sclerosis patients","volume":"44","author":"Gigante","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ejim.2025.03.034_bib0040","first-page":"22","article-title":"Liquid biopsy for cancer cachexia: focus on muscle-derived micrornas","author":"Belli","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejim.2025.03.034_bib0041","first-page":"9","article-title":"Novel concepts in systemic sclerosis pathogenesis: role for MiRNAs","author":"Szabo","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejim.2025.03.034_bib0042","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/art.27443","article-title":"MicroRNA-29, a key regulator of collagen expression in systemic sclerosis","volume":"62","author":"Maurer","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2025.03.034_bib0043","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/MCO.0000000000000645","article-title":"MicroRNAs as potential therapeutic targets for muscle wasting during cancer cachexia","volume":"23","author":"Sannicandro","year":"2020","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.ejim.2025.03.034_bib0044","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.devcel.2009.10.013","article-title":"A Family of MicroRNAs encoded by myosin genes governs myosin expression and muscle performance","volume":"17","author":"van Rooij","year":"2009","journal-title":"Dev Cell"},{"key":"10.1016\/j.ejim.2025.03.034_bib0045","first-page":"124","article-title":"The role of MicroRNA in cancer cachexia and muscle wasting: a review article","volume":"12","author":"Sutandyo","year":"2021","journal-title":"Casp. J. Intern. Med."},{"key":"10.1016\/j.ejim.2025.03.034_bib0046","doi-asserted-by":"crossref","first-page":"8721","DOI":"10.1073\/pnas.0602831103","article-title":"Myogenic factors that regulate expression of muscle-specific MicroRNAs","volume":"103","author":"Rao","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejim.2025.03.034_bib0047","first-page":"5","article-title":"Expression profiling of mammalian MicroRNAs uncovers a subset of brain-expressed MicroRNAs with possible roles in murine and human neuronal differentiation","author":"Sempere","year":"2004","journal-title":"Genome Biol"},{"key":"10.1016\/j.ejim.2025.03.034_bib0048","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ng1725","article-title":"The role of MicroRNA-1 and MicroRNA-133 in skeletal muscle proliferation and differentiation","volume":"38","author":"Chen","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejim.2025.03.034_bib0049","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1016\/j.bbagen.2015.09.020","article-title":"MicroRNA expression and protein acetylation pattern in respiratory and limb muscles of Parp-1(-\/-) and Parp-2(-\/-) mice with lung cancer cachexia","volume":"1850","author":"Chacon-Cabrera","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ejim.2025.03.034_bib0050","first-page":"145","article-title":"MiR-133-mediated regulation of the hedgehog pathway orchestrates embryo myogenesis","author":"Mok","year":"2018","journal-title":"Development"},{"key":"10.1016\/j.ejim.2025.03.034_bib0051","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s12031-015-0548-z","article-title":"MiR-206, a cerebellum enriched MiRNA is downregulated in all medulloblastoma subgroups and its overexpression is necessary for growth inhibition of medulloblastoma cells","volume":"56","author":"Panwalkar","year":"2015","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.ejim.2025.03.034_bib0052","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00296-010-1615-y","article-title":"MicroRNA array analysis of MicroRNAs related to systemic scleroderma","volume":"32","author":"Li","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.ejim.2025.03.034_bib0053","first-page":"1","article-title":"Aberrant repair and fibrosis development in skeletal muscle","author":"Mann","year":"2011","journal-title":"Skelet Muscle"},{"key":"10.1016\/j.ejim.2025.03.034_bib0054","first-page":"807","article-title":"Increased wnt signaling during aging alters muscle stem cell fate and increases fibrosis","volume":"317","author":"Brack","year":"2007","journal-title":"Science (1979)"},{"issue":"18247","key":"10.1016\/j.ejim.2025.03.034_bib0055","article-title":"MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met \/PI3k\/Akt\/MTOR pathway","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejim.2025.03.034_bib0056","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.12659\/MSM.898883","article-title":"MiR-206 suppresses the progression of coronary artery disease by modulating vascular endothelial growth factor (VEGF) expression","volume":"22","author":"Wang","year":"2016","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.ejim.2025.03.034_bib0057","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s10067-022-06059-5","article-title":"Symptoms related to gastrointestinal tract involvement and low muscularity in systemic sclerosis","volume":"41","author":"Rosato","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ejim.2025.03.034_bib0058","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1128\/MCB.01009-10","article-title":"MiR-206 and -486 induce myoblast differentiation by downregulating Pax7","volume":"31","author":"Dey","year":"2011","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ejim.2025.03.034_bib0059","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1073\/pnas.1000300107","article-title":"Regulation of PI3-Kinase\/Akt Signaling by muscle-enriched MicroRNA-486","volume":"107","author":"Small","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejim.2025.03.034_bib0060","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ki.2012.84","article-title":"Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by MicroRNA-486","volume":"82","author":"Xu","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2025.03.034_bib0061","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.598964","article-title":"Tiny regulators of massive tissue: microRNAs in skeletal muscle development, myopathies, and cancer cachexia","volume":"10","author":"Singh","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejim.2025.03.034_bib0062","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1158\/0008-5472.CAN-13-2817","article-title":"Cancer affects MicroRNA expression, release, and function in cardiac and skeletal muscle","volume":"74","author":"Chen","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejim.2025.03.034_bib0063","first-page":"1","article-title":"The anti-fibrotic effects and mechanisms of MicroRNA-486-5p in Pulmonary Fibrosis","volume":"5","author":"Ji","year":"2015","journal-title":"Sci Rep 2015 51"},{"key":"10.1016\/j.ejim.2025.03.034_bib0064","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1182\/blood-2014-06-581926","article-title":"MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors","volume":"125","author":"Wang","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2025.03.034_bib0065","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/ar2598","article-title":"Hypoxia in the pathogenesis of systemic sclerosis","volume":"11","author":"Beyer","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ejim.2025.03.034_bib0066","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263369","article-title":"Hypoxia-induced interstitial transformation of microvascular endothelial cells by mediating HIF-1\u03b1\/VEGF signaling in systemic sclerosis","volume":"17","author":"Mao","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2025.03.034_bib0067","doi-asserted-by":"crossref","first-page":"72835","DOI":"10.18632\/oncotarget.20427","article-title":"The MiR-486-5p plays a causative role in prostate cancer through negative regulation of multiple tumor suppressor pathways","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejim.2025.03.034_bib0068","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.bbrc.2016.01.084","article-title":"MiRNA-486 regulates angiogenic activity and survival of mesenchymal stem cells under hypoxia through modulating Akt signal","volume":"470","author":"Shi","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"issue":"R11","key":"10.1016\/j.ejim.2025.03.034_bib0069","article-title":"Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers","volume":"4","author":"Distler","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.ejim.2025.03.034_bib0070","first-page":"73","article-title":"Phase angle could be a marker of microvascular damage in systemic sclerosis","author":"Gigante","year":"2020","journal-title":"Nutrition"},{"key":"10.1016\/j.ejim.2025.03.034_bib0071","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jdermsci.2022.12.010","article-title":"LncRNA-ZNF252P-AS1\/MiR-15b-5p promotes the proliferation of keloid fibroblast by regulating the BTF3-STAT3 signaling pathway","volume":"108","author":"Guo","year":"2022","journal-title":"J Dermatol Sci"},{"issue":"10","key":"10.1016\/j.ejim.2025.03.034_bib0072","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nrrheum.2014.53","article-title":"Fibrosis\u2014A lethal component of systemic sclerosis","volume":"107","author":"Ho","year":"2014","journal-title":"Nat Rev Rheumatol 2014"},{"key":"10.1016\/j.ejim.2025.03.034_bib0073","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/wrr.12923","article-title":"Keloid tissue analysis discredits a role for myofibroblasts in disease pathogenesis","volume":"29","author":"Bell","year":"2021","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.ejim.2025.03.034_bib0074","first-page":"12","article-title":"Recent insights into cellular and molecular mechanisms of defective angiogenesis in systemic sclerosis","author":"Romano","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejim.2025.03.034_bib0075","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.clnu.2012.08.001","article-title":"Low Phase angle determined by bioelectrical impedance analysis is associated with malnutrition and nutritional risk at hospital admission","volume":"32","author":"Kyle","year":"2013","journal-title":"Clin Nutr"},{"key":"10.1016\/j.ejim.2025.03.034_bib0076","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1136\/ard.2010.139857","article-title":"Identification of novel MicroRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 Regulates aberrant T cell responses through regulation of PDCD4 expression","volume":"70","author":"Stagakis","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2025.03.034_bib0077","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056280","article-title":"MiR-21 promotes fibrogenic epithelial-to-mesenchymal transition of epicardial mesothelial cells involving programmed cell death 4 and Sprouty-1","volume":"8","author":"Br\u00f8nnum","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2025.03.034_bib0078","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.4155\/fmc-2021-0096","article-title":"The role of MicroRNA-21 in the onset and progression of Cancer","volume":"13","author":"Singh","year":"2021","journal-title":"Fut Med Chem"},{"key":"10.1016\/j.ejim.2025.03.034_bib0079","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1073\/pnas.1402714111","article-title":"Microvesicles containing MiRNAs promote muscle cell death in cancer cachexia via TLR7","volume":"111","author":"He","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejim.2025.03.034_bib0080","first-page":"1555","article-title":"Prognostic impact of sarcopenia and its correlation with circulating MiR-21 in colorectal cancer patients","volume":"39","author":"Okugawa","year":"2018","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ejim.2025.03.034_bib0081","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/ijd.13308","article-title":"Inhibition of MicroRNA-21 induces apoptosis in dermal fibroblasts of patients with systemic sclerosis","volume":"55","author":"Jafarinejad-Farsangi","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ejim.2025.03.034_bib0082","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s10875-011-9647-y","article-title":"MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma","volume":"32","author":"Zhu","year":"2012","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ejim.2025.03.034_bib0083","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/rheumatology\/keab300","article-title":"Circulating plasma MicroRNAs in systemic sclerosis-associated pulmonary arterial hypertension","volume":"61","author":"Wuttge","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.ejim.2025.03.034_bib0084","first-page":"883","article-title":"Exosomes derived from bone marrow mesenchymal stem cells promote angiogenesis in ischemic stroke mice via upregulation of MiR-21-5p","volume":"12","author":"Hu","year":"2022","journal-title":"Biomol"},{"key":"10.1016\/j.ejim.2025.03.034_bib0085","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/jcb.29896","article-title":"The role of MiR-29 family in disease","volume":"122","author":"Horita","year":"2021","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.ejim.2025.03.034_bib0086","first-page":"9","article-title":"MiR-29a reduces TIMP-1 production by dermal fibroblasts via targeting TGF-\u03b2 activated kinase 1 binding protein 1, implications for systemic sclerosis","author":"Ciechomska","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2025.03.034_bib0087","first-page":"9","article-title":"Differential MicroRNA expression levels in cutaneous acute graft-versus-host disease","author":"Earls","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejim.2025.03.034_bib0088","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/08916934.2015.1077232","article-title":"MiRNA-29a in systemic sclerosis: a valid target","volume":"48","author":"O'Reilly","year":"2015","journal-title":"Autoimmunity"},{"issue":"7","key":"10.1016\/j.ejim.2025.03.034_bib0089","first-page":"1","article-title":"Integration of MicroRNA and MRNA expression profiles in the skin of systemic sclerosis patients","volume":"71","author":"Zhou","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejim.2025.03.034_bib0090","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/art.27443","article-title":"MicroRNA-29, a key regulator of collagen expression in systemic sclerosis","volume":"62","author":"Maurer","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2025.03.034_bib0091","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jdermsci.2010.11.007","article-title":"Circulating MiR-29a levels in patients with scleroderma spectrum disorder","volume":"61","author":"Kawashita","year":"2011","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.ejim.2025.03.034_bib0092","first-page":"21","article-title":"Exosomes isolated from serum of systemic sclerosis patients display alterations in their content of profibrotic and antifibrotic MicroRNA and induce a profibrotic phenotype in cultured normal dermal fibroblasts","volume":"35","author":"Wermuth","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ejim.2025.03.034_bib0093","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.biochi.2013.03.010","article-title":"MicroRNA-29 family, a crucial therapeutic target for fibrosis diseases","volume":"95","author":"He","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.ejim.2025.03.034_bib0094","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/cei.13599","article-title":"Endothelial-to-mesenchymal transition in systemic sclerosis","volume":"205","author":"Di Benedetto","year":"2021","journal-title":"Clin Exp Immunol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525001281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525001281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T20:36:08Z","timestamp":1746218168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620525001281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":94,"alternative-id":["S0953620525001281"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2025.03.034","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential modulations of miRNAs in patients with systemic sclerosis-associated skeletal muscle loss","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2025.03.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}]}}